Sun Pharma: Full Form, Profile, Latest Revenue and Financials Details

Company profile is the section where you can have a brief description about well established and financially sound companies that are listed in the Indian Stock Exchanges. This section will provide a keen overview about the company in terms of its origin, founders, latest financial reports and much more. We will try to make this article as informative as possible so that virtually this page becomes the Sun Pharma Wiki for a stock market beginner. This week we would be exploring Sun Pharma who is one of the highly reputed multinational pharmaceutical company which primarily operates in India and United States. Companies Origin & Profile: Brief Company Profile: Sun Pharma Industries was established in the year 1983 in Vapi, Gujarat Within the 2 years span it has extended its sales throughout nation. Subsequently the company has launched cardiology drugs in the year 1987 accompanied by gastroenterology drugs in the year 1989. With global revenues of US$ 4.5 billion, Sun Pharma is the fifth largest specialty generic pharmaceutical company in the world. Mainly markets outside India contributes to over 72% of Sun Pharma sales US is the sole gigantic market, considering about 50% business; in all, 93% of turnover is captured by finished dosage forms and formulations. Inception & Founders: Sun Pharma Industries was incorporated by Mr Dilip Shanghvi. Starting with five products that were used to cure psychiatry ailments. Chairman & Directors: Mr Israel Makov is the Chairman and Mr Dilip Shanghvi is the managing director of Sun Pharma Industries Limited. Customer Segment & Area of Operations: Sun Pharma has a diverse and highly independent portfolio of speciality and generic products focusing on a vast range of acute and chronic treatments. Its products cover the full range of ointments, capsules, tablets, liquids and creams. The remedical segments consists of more than 2000 high quality molecules which consists of neurology, urology, gastroenterology, diabetology, dental and nutritionals among others. Besides this it also capable of manufacturing Active Pharmaceutical Ingredients(APIs), anti- retrovirals(ARV’s) and over-the-counter(OTC) among others. Confidence Booster for Investors: The following pointers will uplift the confidence of any stock market analyst. As this highlight the favourable business outcomes for Sun Pharma.

• Sales growth for the past 3 years has been at 25.22 %.
• Having highest market cap in the pharma industry at Rs 140564.43 Cr.
• The compounded profit growth of the past 5 years at been at 23.02%.

Quick Financial Information(Last Updated on 02/08/2018): Following table highlights Key ratios and financial variables which will help investors a lot.

Particulars	Info
Current Price:	585.85
52 weeks High / Low	608.55 / 433.15
Market Cap:	140,564 Cr.
Stock P/E:	41.38
Face Value	1
ROCE:	21.01 %
Book Value:	163.58
Dividend Yield:	0.60 %
Sales Growth (3Yrs):	25.22 %
Listed on	BSE and NSE
ROE:	19.86 %

Shareholding pattern: The table below highlights the approximate shareholding pattern of Sun Pharma.

Holder's Name	% Shareholding
Promoters	54.38%
Foreign Institutions	16.40%
Banks and Mutual Funds	8.41%
Financial Institutions	8.17%
General Public	6.97%
Others	5.67%

Peer Comparison: The table below highlights the Top 7 companies in the same business, therefore, giving the easy benchmark for comparing Sun Pharma with other 6 companies in the same business.

S.No.	Name	CMP Rs.	P/E	Mar Cap Rs.Cr.	Div Yld %	NP Qtr Rs.Cr.	Qtr Profit Var %	Sales Qtr Rs.Cr.	Qtr Sales Var %	ROCE %
1	Piramal Enterp.	2,794	10	50,465	1	-69.81	-33.36	2902.49	29.24	28.33
2	Sun Pharma.Inds.	586	41	140,564	1	1528.99	10.35	6977.1	-2.24	21.01
3	Unichem Labs.	236.4	0.66	1662.91	2.11	-20.65	-1476.67	201.43	42.54	-15.38
4	Aurobindo Pharma	623.15	15.07	36510.83	0.4	528.51	-0.74	4049.09	11.19	27.6
5	Cadila Health.	377.3	21.75	38625.81	0.93	590.8	53.26	3250.2	31.77	21.04
6	Lupin	886	25.33	40060.78	0.56	-777.6	42.48	4033.83	-5.16	11.24
7	Claris Lifescien	396.55	1.37	2163.88	0.5	-317.43	-1809.37	2.07	-54.51	-10.91

Annual & Quarterly Results: Below is the Quarterly Results of Sun Pharma

	Mar 2018	Dec 2017	Sep 2017	Jun 2017	Mar 2017	Dec 2016
Sales	6,977	6,653	6,650	6,208	7,136	7,925
Expenses	5,293	5,199	5,274	6,063	5,589	5,471
Operating Profit	1,683	1,453	1,375	145	1,547	2,453
OPM %	24.13%	21.84%	20.68%	2.34%	21.68%	30.95%
Other Income	302	129	254	151	224	122
Depreciation	455	339	358	346	338	306
Interest	155	95	157	109	44	166
Profit before tax	1,375	1,147	1,114	-158	1,388	2,102
Tax	-176	748	111	161	44	372
Net Profit	1,528	400	1,001	-322	1,385	1,721

Annual Results of Sun Pharma

	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Sales	31,578	28,487	27,392	16,080	11,130	8,019
Expenses	21,489	21,013	19,763	11,598	6,824	4,816
Operating Profit	10,089	7,473	7,628	4,482	4,306	3,203
OPM %	31.95%	26.23%	27.85%	27.87%	38.69%	39.94%
Other Income	623	658	547	552	388	471
Interest	399	523	578	44	43	28
Depreciation	1,264	1,037	1,194	409	336	291
Profit before tax	9,047	6,570	6,402	4,581	4,314	3,355
Tax	1,211	913	914	702	845	313
Net Profit	6,964	4,545	4,539	3,141	2,983	2,656

Cash Flow statement: Readers will find the cash flow statements of Sun Pharma of past 6 years.

	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Cash from Operating Activity	7,082	6,685	5,615	3,959	3,356	2,234
Cash from Investing Activity	-4,186	-3,949	-1,502	-2,176	-2,375	-747
Cash from Financing Activity	-2,285	-1,888	-1,186	506	-664	-544
Net Cash Flow	610	848	2,926	2,289	316	942

Balance Sheet: The below table highlights the balance sheet position of Sun Pharma for the past 6 years.

	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013	Mar 2012
Share Capital	239	240	207	207	103	103
Reserves	36,399	32,741	25,378	18,317	14,886	12,132
Borrowings	9,831	8,496	8,996	2,560	259	320
Other Liabilities	15,440	14,463	14,635	8,298	5,343	3,945
Total Liabilities	61,911	55,941	49,217	29,384	20,592	16,502
Fixed Assets	17,675	15,872	12,682	6,817	5,647	3,951
CWIP	2,801	2,175	2,038	841	562	344
Investments	1,191	1,829	2,716	2,786	2,411	2,212
Other Assets	40,243	36,064	31,780	18,939	11,971	9,993
Total Assets	61,911	55,941	49,217	29,384	20,592	16,502

For more useful articles on trading, investing and market knowledge, visit our Knowledge Center section. (Note: The above list is for information purpose only. Avoid trading and investing based on the information given above. Before investing in stocks do due diligence).